A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

Clinical Rehabilitation

Volumn 17, Issue 1, 2003, Pages 21-29

  Wade, Derick T ^a   Robson, Philip ^b   House, Heather ^a   Makela, Petra ^a   Aram, Julia ^a  

^a OXFORD CENTRE FOR ENABLEMENT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CANNABIS; DRONABINOL; FLAVONOID; NABILONE; PLACEBO; TERPENOID DERIVATIVE;

ANALGESIA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BALANCE DISORDER; BLADDER CONTRACTION; BRACHIAL PLEXUS INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INTOXICATION; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERABILITY; FALLING; FATIGUE; FEMALE; FLU LIKE SYNDROME; FREQUENCY ANALYSIS; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; HYPOTENSION; LIMB AMPUTATION; MALE; MEDICAL RECORD; MOOD; MOUTH DISEASE; MULTIPLE SCLEROSIS; MUSCLE SPASM; NAUSEA; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; OUTPATIENT CARE; PREDICTION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SENSORY DYSFUNCTION; SOMNOLENCE; SPASTICITY; SPINAL CORD INJURY; SYMPTOMATOLOGY; THIRST; TITRIMETRY; VERTIGO; VISUAL ANALOG SCALE; VOMITING; WELLBEING;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; CANNABIDIOL; CANNABIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPOTENSION; MUSCLE SPASTICITY; NERVOUS SYSTEM DISEASES; PAIN; PHYTOTHERAPY; PLACEBOS; PLANT PREPARATIONS; SEVERITY OF ILLNESS INDEX; SPASM; TETRAHYDROCANNABINOL; URINATION DISORDERS;

EID: 0345669751     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215503cr581oa     Document Type: Article

References (22)

1. Baker D, Pryce G, Croxford JL et al. Canninoids control spasticity and tremor in multiple sclerosis model. Nature 2000; 404: 84-87.
2. Grinspoon L, Bakalar JB. Marihuana, the forbidden medicine. New Haven: Yale University Press, 1993.
3. Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38: 44-48.
4. Dunn M, Davis R. The perceived effects of marijuana on spinal cord injured males. Paraplegia 1974; 12: 175.
5. Meinck HM, Schonle PW, Conrad B. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 1989; 236: 120-22.
6. Clifford DB. Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 1983; 13: 669-71.
7. Petro DJ, Ellenberger C. Treatment of human spasticity with delta-9-THC. J Clin Pharmacol 1981; 21: 413S-16S.
8. Ungerleider T, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Substance Abuse 1987; 7: 39-50.
9. Martyn CN, Illis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet 1995; 345: 579.
10. House of Lords Select Committee on Science and Technology (1998) 'Ninth Report'. London.
11. Institute of Medicine. The medical value of marijuana and related substances. In: Joy JE, Watson SJ, Benson JA eds. Marijuana and medicine: assessing the science base. Washington DC: National Academy Press, 1999.
12. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001; 323: 13-16.
13. Killstein J, Hoogervorst EL, Reif M et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002; 58: 1404-1407.
14. McPartland J, Russo E. Cannabis and cannabis extracts: greater than the sum of their parts? J Cannabis Ther 2001; 1: 103-32.
15. Whittle BA, Guy GW, Robson P. Prospects for new cannabis-based prescription medicines. J Cannabis Ther 2001; 1: 183-205.
16. Robson PJ, Guy GW. Clinical studies of cannabis medicines. In: Cannabis and cannabinoids as medicines. London: Pharmaceutical Press (in press).
17. Wade DT, Vergis E. The Short Orientation-Memory-Concentration test: a study of its reliability and validity. Clin Rehabil 1999; 13: 164-70.
18. Collin C, Wade DT, Davis S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988; 10: 61-63.
19. Forlander DA, Bohannon RW. Rivermead Mobility Index: a brief review of research to date. Clin Rehabil 1999; 13: 97-100.
20. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979; 9: 139-45.
21. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the Modified Ashworth scale as clinical tools for assessing post-stroke spasticity. Arch Phys Med Rehabil 1999; 80: 1013-16.
22. Heller A, Wade DT, Wood VA, Sunderland A, Langton Hewer R, Ward E. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry 1987; 50: 714-19.